Market News

Top Momentum Stocks to Watch Top Momentum Stocks to Watch for February 2nd

Investors have a keen eye on three stock options for February 2nd, demonstrating strong momentum and a buy rank:

The Bank of New York Mellon Corporation (BK)

The Bank of New York Mellon Corporation, a leading provider of financial products and services, currently holds a Zacks Rank #1. The company has experienced a 3.8% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.

The Bank of New York Mellon Corporation Price and Consensus

The Bank of New York Mellon Corporation’s shares have surged by 22.6% over the last three months, outperforming the S&P 500’s advance of 10.8%. Its Momentum Score stands at B.

The Bank of New York Mellon Corporation Price

HCA Healthcare, Inc. (HCA)

HCA Healthcare, a provider of healthcare services, holds a Zacks Rank #1. The company has observed a 1.4% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.

HCA Healthcare, Inc. Price and Consensus

HCA Healthcare’s shares have seen a remarkable 36.3% surge over the last three months, surpassing the S&P 500’s growth rate of 10.8%. The company boasts a Momentum Score of A.

HCA Healthcare, Inc. Price

HOOKIPA Pharma Inc. (HOOK)

HOOKIPA Pharma Inc., a biopharmaceutical company, possesses a Zacks Rank #1 and has witnessed a 1.1% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days.

See also  The Dawn of a New Era: Oracle (ORCL) and NVIDIA Join Forces to Revolutionize Sovereign AI Solutions

HOOKIPA Pharma Inc. Price and Consensus

HOOKIPA Pharma’s shares have spiked by 38.9% over the last three months, exceeding the S&P 500’s growth rate of 10.8%. The company holds a Momentum Score of B.

HOOKIPA Pharma Inc. Price

Find the full list of top-ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Just Released: Zacks Top 10 Stocks for 2024

Hurry – you can still get in early on our 10 top tickers for 2024. Hand-picked by Zacks Director of Research, Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2023, the Zacks Top 10 Stocks gained +974.1%, nearly TRIPLING the S&P 500’s +340.1%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2024. You can still be among the first to see these just-released stocks with enormous potential.

See New Top 10 Stocks >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Zacks Investment Research